ABSTRACT
INTRODUCTION

40
Cervical cancer is the second most common gynecologic malignancy in the world [1] .
41
In addition to surgery and radiotherapy, neoadjuvant chemotherapy (NAC) followed by 42 surgery has been used to treat locally advanced cervical cancer [2] . Because the prognosis of 43 patients with cervical cancer depends largely on lymph node (LN) metastasis [3] [4] [5] , it is 44 important to assess the LN status accurately before starting treatment.
45
Based on studies comparing the size of the LNs in images and pathological diagnoses, 46 a 10 mm short-axis diameter became the currently accepted cut-off in both clinical practice 47 and clinical trials [6] [7] [8] . However, the sensitivity of this conventional criterion has been 48 reported to be as low as 25% [9] . Furthermore, previous studies have generally predicted the 49 presence of LN metastases in the patient without describing the location. In the present study, 50 we conducted a detailed, region-by-region analysis to generate a new criterion that could 51 identify region-specific, swollen LNs. The use of our criterion could lead to the improvement 52 of individualized treatments.
53
In conducting the detailed analysis of LN status, the width of the slices, 7 mm in 54 conventional CT and 5 mm in MRI, was considered to be a key limitation [7] . We therefore 55 used a multi-detector CT (MDCT) scanner, which allowed one mm slice images [10, 11] . Using MDCT, we successfully generated a new criterion to diagnose LN metastasis. Using 57 the new criterion, we were able to examine the efficacy of NAC in eradicating LN metastases 58 in a region-by-region manner for the first time. 
MATERIALS AND METHODS
61
Assessment of MDCT images
62
Patients
63
Patients with stage IA2 to IIB cervical cancer who were being treated in our 64 department were retrospectively analyzed. Staging was performed according to the 65 Classification of International Federation of Gynecology and Obstetrics (FIGO, 1994) [12] .
66
With the written consent of each patient, and under the approval of the ethics committee, we 67 initiated the MDCT study in January 2007: 106 patients underwent MDCT examination 68 within two weeks before surgery; 78 patients underwent primary surgery; and the remaining 69 28 patients received NAC followed by surgery. In Table 1 , we show the number of patients 70 arranged according to their cancer stage.
71
Lymphadenectomy was performed during all of the surgeries, and we resected LNs 72 separately in a region-by-region manner and made pathological diagnoses for each sample.
73
NAC regimen and indication
74
Because squamous cell carcinoma (SCC) was more sensitive than adenocarcinoma to 75 chemotherapy in our preliminary analysis, we administered NAC primarily in stage 76 IB2/IIA/IIB SCC cases (Table 1 ). An intravenous infusion of irinotecan (CPT-11) (60 mg/m 2 77 7 on days one and eight) and nedaplatin (NDP) (80 mg/m 2 on day one) was administered.
78
Cycles were repeated every 21 days. In total, we conducted two cycles of NAC. 
RESULTS
137
Detection of LNs in 1 mm slice images from MDCT.
138
A total of 4,765 LNs were pathologically identified within 980 regions from 106 139 patients, whereas the total number of visible LNs in the MDCT images was 800. Thus, the 140 detection rate of LNs by MDCT was 17% (800/4,765). The most difficult LN to detect was 141 the presacral LN (6%), whereas the easiest was the left common iliac LN (46%) ( Figure 1a ).
142
Only seven of the 800 visible LNs in the MDCT images were over 10 mm in diameter. clinical use. When the 5 mm cut-off was used, the sensitivity, specificity, positive predictive 171 value (PPV), and negative predictive value were 70, 79, 27, and 96%, respectively.
172
Next, we divided all cases into SCC and non-SCC to examine the influence of 
181
We also evaluated the conventional 10 mm cut-off. In the primary surgery cases, only 182 four of all the visible LNs in the MDCT images were over 10 mm in diameter (Figure 2a ).
183
We found that the conventional cut-off of 10 mm was far from the optimal cut-off based on 184 the ROC analyses (Figure 2b, 3b, 3c ). In addition, we randomly divided our data (primary 185 surgery cases, region-by-region data) into three groups and conducted ROC analyses shown). We therefore concluded that the conventional 10 mm cut-off is statistically 188 inappropriate in MDCT images.
189
Assessment of NAC efficacy on metastatic LNs in cervical cancer.
190
We analyzed 153 Reg-LNs from 28 patients who underwent NAC followed by 191 surgery using the MDCT images taken just before surgery. As in the primary surgery cases, 
281
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282
Neoadjuvant chemotherapy followed by radical hysterectomy plus postoperative Figure 2a) . Therefore, the primary operation and NAC were comparable among IB2/IIA cases.
Statistical methods
To analyse the distribution in a 2x2 table, Fisher's exact test was employed. To analyse the distribution in a larger table, the chi-square test was used. We considered p<0.05 a significant difference. Figure 2b) . The overall survival rate of IB2/IIA SCC patients who received NAC was better than primary operation cases (Supplementary Figure 2c) . 
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